Application of imiquimod by suppositories (anal tampons) efficiently prevents recurrences after ablation of anal canal condyloma.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 12366425.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
After surgical removal, anal canal condyloma (ACC) has a higher risk of recurrence compared with extragenital warts. To reduce local recurrences of ACC using follow-up treatment with imiquimod-containing suppositories (anal tampons). After ablation of ACC, 10 male patients received treatment with imiquimod suppositories three times weekly for 3-4 months. Treatment with imiquimod anal tampons was well tolerated. Early initial recurrences in some patients cleared after treatment with the imiquimod suppositories. Within a mean follow-up of 9 months no patient demonstrated recurrence of ACC. These data suggest that imiquimod anal tampons may represent a new therapeutic option to prevent recurrences of ACC following ablative surgery.
Medical subject headings
- Aminoquinolines
- Anus Diseases
- Condylomata Acuminata
- Interferon Inducers